Literature DB >> 19109722

Gain-of-function and loss-of-function strategies in Xenopus.

Danielle L Lavery1, Stefan Hoppler.   

Abstract

Xenopus embryos are particularly suited for functional experiments to investigate vertebrate embryonic development. Due to the large size of embryos and their development outside of the mother organism, they are very accessible, easy to manipulate, and allow for immediate observation of developmental phenotypes. Powerful methods have been established for both gain- and loss-of-function strategies, which build on these inherent advantages. This chapter describes injection methods used to overexpress gene products and inhibit gene expression as well as pharmacological approaches to manipulate Wnt signaling in Xenopus embryos.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109722     DOI: 10.1007/978-1-60327-469-25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Wnt/beta-catenin signalling regulates cardiomyogenesis via GATA transcription factors.

Authors:  Jennifer Martin; Boni A Afouda; Stefan Hoppler
Journal:  J Anat       Date:  2010-01       Impact factor: 2.610

2.  Neural Explant Cultures from Xenopus laevis.

Authors:  Laura Anne Lowery; Anna E R Faris; Alina Stout; David Van Vactor
Journal:  J Vis Exp       Date:  2012-10-15       Impact factor: 1.355

3.  sfrp1 promotes cardiomyocyte differentiation in Xenopus via negative-feedback regulation of Wnt signalling.

Authors:  Natalie Gibb; Danielle L Lavery; Stefan Hoppler
Journal:  Development       Date:  2013-04       Impact factor: 6.868

4.  MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.

Authors:  Ping-Ping He; Xin-Ping OuYang; Yuan Li; Yun-Cheng Lv; Zong-Bao Wang; Feng Yao; Wei Xie; Yu-Lin Tan; Liang Li; Min Zhang; Gang Lan; Duo Gong; Hai-Peng Cheng; Hui-Juan Zhong; Dan Liu; Chong Huang; Zhao-Xia Li; Xi-Long Zheng; Wei-Dong Yin; Chao-Ke Tang
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.